Clinical variation in patient responses to myocardial infarction (MI) has been difficult to model in laboratory animals. To assess the genetic basis of variation in outcomes after heart attack, we characterized responses to acute MI in the Collaborative Cross (CC), a multi-parental panel of genetically diverse mouse strains. Striking differences in post-MI functional, morphological, and myocardial scar features were detected across 32 CC founder and recombinant inbred strains. Transcriptomic analyses revealed a plausible link between increased intrinsic cardiac oxidative phosphorylation levels and MI-induced heart failure. The emergence of significant quantitative trait loci for several post-MI traits indicates that utilizing CC strains is ...
BackgroundGenetic diversity and the heterogeneous nature of cardiac fibroblasts (CFbs) have hindered...
We aimed to understand the genetic control of cardiac remodeling using an isoproterenol-induced hear...
Objective: Clinical experimental stem cell therapy after myocardial infarction appears feasible, but...
Clinical variation in patient responses to myocardial infarction (MI) has been difficult to model in...
Clinical variation in patient responses to myocardial infarction (MI) has been difficult to model in...
Contemporary approaches for developing new interventions and for pre-clinical risk evaluation includ...
The genetics of heart failure is complex. In familial cases of cardiomyopathy, where mutations of la...
Heart failure (HF) accounts for 1 in 9 deaths in the United States and is the leading cause of hospi...
Inbred mouse strains play a critical role in biomedical research. Genetic homogeneity within inbred ...
Mouse models have been used extensively to study human coronary artery disease (CAD) or atherosclero...
A traditional approach to investigate the genetic basis of complex diseases is to identify genes wit...
Heart failure (HF) is the leading cause of death worldwide. It is a complex disease involving multip...
Cardiac ischemia leads to the loss of myocardial tissue and the activation of a repair process that ...
Myocardial Infarction (MI) results in a loss of cardiomyocytes, which stimulates a wound healing res...
Von Willebrand A domain Related Protein (WARP), is a recently identified extracellular matrix protei...
BackgroundGenetic diversity and the heterogeneous nature of cardiac fibroblasts (CFbs) have hindered...
We aimed to understand the genetic control of cardiac remodeling using an isoproterenol-induced hear...
Objective: Clinical experimental stem cell therapy after myocardial infarction appears feasible, but...
Clinical variation in patient responses to myocardial infarction (MI) has been difficult to model in...
Clinical variation in patient responses to myocardial infarction (MI) has been difficult to model in...
Contemporary approaches for developing new interventions and for pre-clinical risk evaluation includ...
The genetics of heart failure is complex. In familial cases of cardiomyopathy, where mutations of la...
Heart failure (HF) accounts for 1 in 9 deaths in the United States and is the leading cause of hospi...
Inbred mouse strains play a critical role in biomedical research. Genetic homogeneity within inbred ...
Mouse models have been used extensively to study human coronary artery disease (CAD) or atherosclero...
A traditional approach to investigate the genetic basis of complex diseases is to identify genes wit...
Heart failure (HF) is the leading cause of death worldwide. It is a complex disease involving multip...
Cardiac ischemia leads to the loss of myocardial tissue and the activation of a repair process that ...
Myocardial Infarction (MI) results in a loss of cardiomyocytes, which stimulates a wound healing res...
Von Willebrand A domain Related Protein (WARP), is a recently identified extracellular matrix protei...
BackgroundGenetic diversity and the heterogeneous nature of cardiac fibroblasts (CFbs) have hindered...
We aimed to understand the genetic control of cardiac remodeling using an isoproterenol-induced hear...
Objective: Clinical experimental stem cell therapy after myocardial infarction appears feasible, but...